Abstract:The lipophilicity and solubility profiles of bis(12)-hupyridone (B12H) and bis(7)-tacrine (B7T), two novel acetylcholinesterase inhibitors dimerized from huperzine A fragments and tacrine, respectively, were investigated over a broad pH range. Lipophilicity was assessed by both shake flask method with 1-octanol–water system and a reverse-phase HPLC system with methanol–water as mobile phase. The former method was used for determining the lipophilicities of the ionized forms (logD) of the dimers while the latter method was used for that of the neutral forms (logP). The logP values for B12H and B7T were found to be 5.4 and 8.2, respectively, indicating that the two dimers are highly lipophilic. The solubilities of both dimers were found to be affected by pH. The solubility of B12H was >1.41mg/ml when the pH was <7, but <0.06mg/ml when the pH was >8. The solubility of B7T was >0.26mg/ml when the pH was <9, but <0.005mg/ml when the pH was >12. The ionic strength of a solution could affect the solubilities considerably (11.16mg/ml for B12H and 12.71mg/ml for B7T in water; 2.07mg/ml for B12H and 0.36mg/ml for B7T in saline). The ionization constants (pKa) of the two dimers were determined by UV spectrophotometry. Both dimers were found to have two pKa values: 7.5±0.1 (pKa1) and 10.0±0.2 (pKa2) for B12H; and 8.7±0.1 (pKa1) and 10.7±0.4 (pKa2) for B7T. Furthermore, an in vivo pharmacological assay conducted in mice showed that a maximum AChE inhibition occurred 15min after the single-dose and intraperitoneal administration of either dimer. This indicates that the two dimers may easily cross the blood–brain barrier. In summary, these physiochemical characteristics suggest that the two dimers may be promising candidates for the development of better drugs for Alzheimer's disease.

The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine.

Synthesis, Biological Activity, and Biopharmaceutical Characterization of Tacrine Dimers As Acetylcholinesterase Inhibitors.

East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.

Design, Synthesis and Evaluation of Rivastigmine and Curcumin Hybrids As Site-Activated Multitarget-Directed Ligands for Alzheimer's Disease Therapy.

Searching for the Multi-Target-Directed Ligands Against Alzheimer’s Disease: Discovery of Quinoxaline-Based Hybrid Compounds with AChE, H3R and BACE 1 Inhibitory Activities

Identification of N-phenyl-3-methoxy-4-pyridinones As Orally Bioavailable H3 Receptor Antagonists and Β-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer's Disease.

Evaluation Of Novel Dual Acetyl- And Butyrylcholinesterase Inhibitors As Potential Anti-Alzheimer'S Disease Agents Using Pharmacophore, 3d-Qsar And Molecular Docking Approaches

A Tacrine-Tetrahydroquinoline Heterodimer Potently Inhibits Acetylcholinesterase Activity and Enhances Neurotransmission in Mice.

Synthesis and evaluation of 6-substituted 3-arylcoumarin derivatives as multifunctional acetylcholinesterase/monoamine oxidase B dual inhibitors for the treatment of Alzheimer’s disease

Novel 16-substituted bifunctional derivatives of huperzine B: multifunctional cholinesterase inhibitors

Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Bis(7)-tacrine, a novel dimeric AChE inhibitor, is a potent GABA(A) receptor antagonist

Effects of Bis(7)-Tacrine, A Novel Anti-Alzheimer'S Agent, on Rat Brain Ache

Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential anti-Alzheimer's Disease Agents.

Promising tacrine/huperzine A‐based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Multipotent Ache and Bace-1 Inhibitors for the Treatment of Alzheimer'S Disease: Design, Synthesis and Bio-Analysis of 7-Amino-1,4-dihydro-2h-isoquilin-3-one Derivates

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning As Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase

Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors

Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.

Inhibition of Cholinesterase Activity and Amyloid Aggregation by Berberine-Phenyl-benzoheterocyclic and Tacrine-Phenyl-benzoheterocyclic Hybrids.

Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Quinoline-Ferulic Acid Hybrids As Cholinesterase Inhibitors.